04/2021 - 03/2025
Horizon 2020 (EU) :
747 584 Euro
Vaccine hesitancy—the delay or refusal of vaccination without medical indication—has been cited as a serious threat to global health by the World Health Organization (WHO), attributing it to misinformation on the internet. The WHO has also identified Health Care Professionals (HCPs) as the most trusted influencers of vaccination decisions. JITSUVAX leverages those insights to turn toxic misinformation into a potential asset based on two premises:
JITSUVAX comprises 4 scientific work packages (WPs 1-4), plus one Management WP (WP0). WP1 will systematically measure HCP attitudes towards vaccinations across participating countries. WP2 will analyse argumentation by anti-vaccination activists to provide material for inoculation and refutational learning. WP2 will also develop novel tools that improve public resilience to misinformation and HCP’s knowledge and attitudes concerning vaccinations. WP3 will translate the findings from WP1 and WP2 into practice, by exploring several new tools, ranging from a new “empathic refutational interview” to interventions in the training of HCPs. WP4 focuses on impact and dissemination. WP4 will design and develop a guidance document for HCPs and public health bodies. Through the team’s contacts and previous collaborations with WHO and UNICEF, we will disseminate and leverage our new knowledge for global impact.
The above data on duration and funding refer to the the University of Erfurt as project partner.
Information on the overall project:
Professor Stephan Lewandowsky, University of Bristol (Koordination Gesamtprojekt)
The Chancellor Masters and Scholars of the University of Cambridge
Observatoire Régional de la Santé
Education, School, and Behaviour